PreciThera is a biotechnology company committed to the development of therapies for rare bone diseases using the combined application of computational technology and a deep understanding of disease pathology. The Company focuses on heterogeneous genetic disorders that primarily manifest in bone dysfunction. In depth understanding of disease mechanism will allow PreciThera’s targeted strategies to meaningfully impact both the skeletal symptoms as well as the extraskeletal issues found in these patients.
|Size (employees)||6 (est)|
PreciThera total Funding
PreciThera latest funding size
Time since last funding
|a year ago|
|CTI Life Sciences Fund, Fonds de solidarité FTQ, Sanderling Ventures, Arix Bioscience, Emerillon Capital|
When was PreciThera founded?
PreciThera was founded in 2016.
Who are PreciThera key executives?
PreciThera's key executives are Pierre Beauparlant.
How many employees does PreciThera have?
PreciThera has 6 employees.
Who are PreciThera competitors?
Competitors of PreciThera include Kyn Therapeutics, Torque and Bioverativ.
Where is PreciThera headquarters?
PreciThera headquarters is located at 408 1010 Rue Sherbrooke Ouest, Montréal.
Where are PreciThera offices?
PreciThera has an office in Montréal.
How many offices does PreciThera have?
PreciThera has 1 office.